By: Thomas Sullivan
Apotex and Heritage Pharmaceuticals, generic drug manufacturers, recently agreed to pay $49.1 million to resolve antitrust allegations put forth by
Thomas Sullivan is a Senior Vice President and journalist for JD Supra and Policy & Medicine Compliance Update. With a focus on legal and policy issues in the healthcare industry, Thomas covers topics such as copyright, FDA regulations, healthcare disparities, Medicare, fraud schemes, mental health, and opioid epidemic. His articles provide insights and updates on important developments in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Based on Thomas Sullivan's coverage, he focuses primarily on healthcare and pharmaceutical legal and regulatory developments. He would likely be most interested in pitches related to government announcements, legal policy regulations, or press releases within the healthcare industry. Given his focus, he may be particularly responsive to insights from experts with a strong understanding of the U.S. healthcare system, including compliance professionals and legal experts specialized in healthcare law.
Thomas does not appear to have a specific geographic focus but pays close attention to federal-level initiatives that impact the broader U.S. healthcare landscape. Therefore, any relevant pitches should consider this national scope when offering expert analysis or commentary within the realm of U.S.-focused health policy and regulation.
This information evolves through artificial intelligence and human feedback. Improve this profile .